Preliminary evidence of clinical activity from phase I and Ib trials of the CLK/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors

This article has no abstract
Epistemonikos ID: f9722d432174d1d2abc0e49aec8c15847f6ffdf4
First added on: Feb 15, 2025